Skip to main content
. 2023 Jun 20;9(2):45–52. doi: 10.1016/j.afos.2023.06.001

Table 14.

Recommendations for teriparatide therapy.

Recommendations Grading of recommendations Quality of evidence
Initial treatment for patients at very high fracture riska I A
Treatment for 1–2 years then, followed by antiresorptive drug I B
May consider in patients with inadequate response to bisphosphonates despite good adherence for ≥ 2 years IIa B
a

For reduction of vertebral and nonvertebral fracture.